Digital Health Nursing Pharmaceuticals Primary Care 
Health Populi
MAY 16, 2023
Strikingly, the trust deficit with retail stores for medical care was substantial, with 80% of consumers telling Wolters Kluwer that they would “probably never” go to a department store for health care. In 5 years, 61% of U.S.
Healthcare IT Today
DECEMBER 11, 2022
A report from Wolters Kluwer suggested that patients are willing to shift primary care to new care settings if it means the cost of care will decrease. More than 45% of respondents said they don’t trust the pharmaceutical industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
DECEMBER 11, 2022
A report from Wolters Kluwer suggested that patients are willing to shift primary care to new care settings if it means the cost of care will decrease. More than 45% of respondents said they don’t trust the pharmaceutical industry.
Health Populi
DECEMBER 28, 2021
Telehealth will help many people meet up with health care access — but not necessarily universally or equitably. Mental health will continue to be the epidemic beyond the pandemic. Healthcare delivery will be omnichannel, featuring digital front doors and new primary care on-ramps.
Healthcare IT News - Telehealth
MARCH 25, 2022
Supported by Y.Elites Association and the Hong Kong Youth Development Alliance, the service runs in two phases: the first round, which has been completed, delivered teleconsultations to low-income families, and the upcoming second round will cover senior people living alone and those living in nursing homes.
Healthcare IT Today
MAY 10, 2023
Sean Lynch, Vice President of Clinical Operations at Curebase A major reason why health disparities exist in clinical trials today can be attributed to the burden traditional trial models place on participating patients. These practitioners ensure that all patients, regardless of socioeconomic status, receive the care they need.
Digital Health Global
NOVEMBER 2, 2023
This resource-intensiveness not only hinders innovation, limiting the development of potentially life-saving drugs, but it also contributes to the elevated prices of pharmaceuticals, posing a significant barrier to healthcare accessibility for many. DiMasi, H.G. Grabowski, and R.W.
Expert insights. Personalized for you.
156 
Let's personalize your content